At a glance
ClinicalIndex Comparison RecordN/ACompleted· 598 enrolled
Drug / intervention
rbcDNA testother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Exploratory Study of a Novel Based rbcDNA Liquid Biopsy Technique for Colorectal Cancer Early Detection
Second Affiliated Hospital, School of Medicine, Zhejiang University·observational·Posted May 25, 2023·Updated Aug 27, 2024
In Brief
An observational study evaluating rbcDNA test for Colorectal Cancer and 3 related conditions. Completed, enrolled 598 participants across 1 site.
Detailed Summary
Exploration of a novel rbcDNA liquid biopsy technique for early detection of colorectal cancer is a promising development in the field of disease diagnosis and screening. This technique has the potential to establish an efficient and sensitive system for the early detection of colorectal cancer, which can provide a new perspective for individual health monitoring.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsColorectal Cancer, Adenomatous Polyps, Adenoma, Advanced Adenoma
CountriesChina
CollaboratorsTiming Biotech Co.Ltd.
Timeline
N/ACompletedFinished
202420252026
Enrollment StartMay 2023
First PostedMay 2023
Primary CompletionDec 2023
Study CompletionJan 2024
TodayJul 2026
First PostedMay 25, 2023
Enrollment StartMay 18, 2023
Primary CompletionDec 28, 2023
Study CompletionJan 10, 2024
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 3.1 years ago
Interventions
rbcDNA testother
fecal immunochemical test